Page last updated: 2024-08-26

1,2-distearoylphosphatidylethanolamine and B16 Melanoma

1,2-distearoylphosphatidylethanolamine has been researched along with B16 Melanoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deng, Y; Hu, L; Liu, X; Liu, Y; Luo, X; Peng, B; Song, Y; Zhang, T; Zhou, S1
Cao, Z; Gao, H; He, Q; Li, J; Liu, Y; Long, Y; Qian, J; Qiu, Y; Shi, K; Wang, Y; Yang, B; Yang, P; Zhang, Q; Zhang, Z1
Bhadra, MP; Bhadra, U; Garikapati, KR; Reddy, BV; Reddy, SG; Reddy, TL; Yadav, JS1
Cai, L; Chen, L; Chen, X; Duan, X; Li, X; Qian, Z; Qiu, N; Wang, W; Wang, X; Wei, Y; Wen, J; Yang, L1
Huang, Y; Lü, WL; Xiong, XB; Zhang, H; Zhang, Q; Zhang, X1

Other Studies

5 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and B16 Melanoma

ArticleYear
Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency.
    Drug delivery and translational research, 2018, Volume: 8, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Drug Liberation; Drug Stability; Epirubicin; Liposomes; Male; Melanoma, Experimental; Mice, Inbred C57BL; Phosphatidylethanolamines; Polyethylene Glycols; Rats, Wistar; Sialic Acids; Tumor Burden

2018
A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Journal of controlled release : official journal of the Controlled Release Society, 2015, Nov-10, Volume: 217

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line; Cell Line, Tumor; Cell Survival; Cell-Penetrating Peptides; Coculture Techniques; Drug Liberation; Female; Humans; Hydrogen-Ion Concentration; Integrin alphaVbeta3; Liposomes; Melanoma, Experimental; Mice, Inbred C57BL; Paclitaxel; Phosphatidylethanolamines; Polyethylene Glycols

2015
Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma.
    Scientific reports, 2016, 10-27, Volume: 6

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drug Compounding; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Hydrogen-Ion Concentration; Imidazoles; Liposomes; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Phosphatidylethanolamines; Proto-Oncogene Proteins c-bcl-2; Pyrones; RNA, Small Interfering; Skin Neoplasms; Tumor Burden

2016
Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo.
    International journal of nanomedicine, 2012, Volume: 7

    Topics: Animals; Antineoplastic Agents; Area Under Curve; Binding Sites; Cell Line, Tumor; Cholesterol; Drug Stability; Female; Humans; Ligands; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Peptides; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Random Allocation; Receptors, Fibroblast Growth Factor; Tissue Distribution

2012
[Preparation of doxorubicin-loaded stealth liposomes modified with RGD mimetic and cellular association in vitro].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2005, Volume: 40, Issue:12

    Topics: Animals; Antibiotics, Antineoplastic; Cell Adhesion; Cell Line, Tumor; Cell Nucleus; Doxorubicin; Drug Carriers; Drug Delivery Systems; Humans; Liposomes; Melanoma, Experimental; Oligopeptides; Phosphatidylethanolamines; Polyethylene Glycols

2005